Evavold B D, Sloan-Lancaster J, Wilson K J, Rothbard J B, Allen P M
Department of Pathology Washington University School of Medicine, St. Louis, Missouri 63110, USA.
Immunity. 1995 Jun;2(6):655-63. doi: 10.1016/1074-7613(95)90010-1.
The T cell receptor (TCR) can interact with a spectrum of peptides as part of its ligand, including the immunogenic peptide, variants of this peptide,and apparently unrelated peptides. The basis of this broad specificity for ligand was investigated by substitution analysis of a peptide antigen and functional testing using a B cell apoptosis assay. A peptide containing as few as 1 aa in common with this peptide could stimulate a specific T cell response. Two endogenous ligands, an agonist and a partial agonist, were readily identified from a search of the SwissProt database, indicating that multiple endogenous ligands likely exist for a given T cell. These findings strongly support the concept that one TCR has the ability to interact productively with multiple different ligands, and provide evidence that such ligands exist in the endogenous peptide repertoire.
作为其配体的一部分,T细胞受体(TCR)可与一系列肽相互作用,包括免疫原性肽、该肽的变体以及明显不相关的肽。通过对肽抗原进行置换分析并使用B细胞凋亡检测进行功能测试,研究了这种对配体的广泛特异性的基础。与该肽仅有1个氨基酸相同的肽就能刺激特异性T细胞反应。通过搜索SwissProt数据库,很容易鉴定出两种内源性配体,一种激动剂和一种部分激动剂,这表明给定的T细胞可能存在多种内源性配体。这些发现有力地支持了一个TCR能够与多种不同配体有效相互作用的概念,并提供了证据表明此类配体存在于内源性肽库中。